Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trialHilko Ardon, Steven De Vleeschouwer, Steffen Fieuws et al.|Cancer Immunology Immunotherapy|2012Cited by 162
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot studyHilko Ardon, Steven De Vleeschouwer, Stefaan Van Gool et al.|Journal of Neuro-Oncology|2010Cited by 146